TAYLOR WHITE: Open Payments
NPI 1215407960 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 42 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $236 · 2025 $1,117
Food & beverage: $1,033Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $191 |
| Gilead Sciences, Inc. | 3 | $177 |
| Madrigal Pharmaceuticals | 4 | $160 |
| Janssen Biotech, Inc. | 5 | $148 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Aimmune Therapeutics, Inc. | 4 | $79 |
| Ardelyx, Inc. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 6 | $47 |
| PFIZER INC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: REZDIFFRA, TREMFYA, INGREZZA, Livdelzi, ZENPEP, LINZESS, SKYRIZI, IBSRELA.
Industry payments across FL — which companies pay providers there.
